CGX1037 is a novel PKC isoform delta selective inhibitor in platelets

References

• Packham MA. Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol 1994;72:278–284
   PubMed Web of Science ®Google Scholar
• Quinton TM, Kim S, Dangelmaier C, Dorsam RT, Jin J, Daniel JL, Kunapuli SP. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation. Biochem J 2002;368:535–543
   PubMed Web of Science ®Google Scholar
• Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev 2008;88:1341–1378
   PubMed Web of Science ®Google Scholar
• Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J 1998;332:281–292
   PubMed Web of Science ®Google Scholar
• Violin JD, Newton AC. Pathway illuminated: Visualizing protein kinase C signaling. IUBMB Life 2003;55:653–660
   Google Scholar
• Crosby D, Poole AW. Physical and functional interaction between protein kinase C delta and Fyn tyrosine kinase in human platelets. J Biol Chem 2003;278:24533–24541
   PubMedGoogle Scholar
• Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 1993;268:9194–9197
   PubMed Web of Science ®Google Scholar
• Murugappan S, Tuluc F, Dorsam RT, Shankar H, Kunapuli SP. Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets. J Biol Chem 2004;279:2360–2367
   PubMed Web of Science ®Google Scholar
• Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771–15781
   PubMed Web of Science ®Google Scholar
• Bhavanasi D, Kim S, Goldfinger LE, Kunapuli SP. Protein kinase Cdelta mediates the activation of protein kinase D2 in platelets. Biochem Pharmacol 2011;82:720–727
   Google Scholar
• Bynagari-Settipalli YS, Chari R, Kilpatrick L, Kunapuli SP. Protein kinase C - possible therapeutic target to treat cardiovascular diseases. Cardiovasc Hematol Disord Drug Targets 2010;10:292–308
   Google Scholar
• Chari R, Getz T, Nagy B, Jr Bhavaraju K, Mao Y, Bynagari YS, Murugappan S, Nakayama K, Kunapuli SP. Protein kinase C[delta] differentially regulates platelet functional responses. Arterioscler Thromb Vasc Biol 2009;29:699–705
   Google Scholar
• Chari R, Kim S, Murugappan S, Sanjay A, Daniel JL, Kunapuli SP. Lyn, PKC-delta, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion. Blood 2009;114:3056–3063
   Google Scholar
• Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 1994;199:93–98
   PubMed Web of Science ®Google Scholar
• Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95–105
   PubMed Web of Science ®Google Scholar
• Leitges M, Elis W, Gimborn K, Huber M. Rottlerin-independent attenuation of pervanadate-induced tyrosine phosphorylation events by protein kinase C-delta in hemopoietic cells. Lab Invest 2001;81:1087–1095
   PubMedGoogle Scholar
• Nguyen KT, Shin JW, Rae C, Nanitsos EK, Acosta GB, Pow DV, Buljan V, Bennett MR, Else PL, Balcar VJ. Rottlerin inhibits (Na+, K+)-ATPase activity in brain tissue and alters D-aspartate dependent redistribution of glutamate transporter GLAST in cultured astrocytes. Neurochem Res 2009;34:1767–1774
   Google Scholar
• Susarla BT, Robinson MB. Rottlerin, an inhibitor of protein kinase Cdelta (PKCdelta), inhibits astrocytic glutamate transport activity and reduces GLAST immunoreactivity by a mechanism that appears to be PKCdelta-independent. J Neurochem 2003;86:635–645
   PubMed Web of Science ®Google Scholar
• Tapia JA, Jensen RT, Garcia-Marin LJ. Rottlerin inhibits stimulated enzymatic secretion and several intracellular signaling transduction pathways in pancreatic acinar cells by a non-PKC-delta-dependent mechanism. Biochim Biophys Acta 2006;1763:25–38
   Google Scholar
• Kayali AG, Austin DA, Webster NJ. Rottlerin inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes by uncoupling mitochondrial oxidative phosphorylation. Endocrinology 2002;143:3884–3896
   Google Scholar
• Soltoff SP. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation. J Biol Chem 2001;276:37986–37992
   PubMedGoogle Scholar
• Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A 2001;98:11114–11119
   PubMed Web of Science ®Google Scholar
• Balasubramanian V, Onaca O, Enea R, Hughes DW, Palivan CG. Protein delivery: From conventional drug delivery carriers to polymeric nanoreactors. Expert Opin Drug Deliv 7:63–78
   Google Scholar
• Up. Functional gene array in yeast
   Google Scholar
• Carles M LM, Goolaerts A, Roux J, Song Y, Howard M, Weston D, Swindle JT, Hedgpeth J, Burel-Vandenbos F, Pittet JF. Critical role of the small GTPase RhoA in the development of pulmonary edema induced by Pseudomonas aeruginosa in mice. Anesthesiology 2010;113:1134–1143
   Google Scholar
• Yee JK MC, Hummel HS, Lim S, Sugano S, Rahan VK, Xiao G, Lee WN. Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells. J Lipid Research 2008;49:2124–2134
   Google Scholar
• Konopatskaya O, Matthews SA, Harper MT, Gilio K, Cosemans JM, Williams CM, Navarro MN, Carter DA, Heemskerk JW, Leitges M, et al. Protein kinase C mediates platelet secretion and thrombus formation through protein kinase D2. Blood 118:416–424
   Google Scholar
• Newton AC. Regulation of protein kinase C. Curr Opin Cell Biol 1997;9:161–167
   PubMed Web of Science ®Google Scholar
• Konopatskaya O, Gilio K, Harper MT, Zhao Y, Cosemans JM, Karim ZA, Whiteheart SW, Molkentin JD, Verkade P, Watson SP, et al. PKCalpha regulates platelet granule secretion and thrombus formation in mice. J Clin Invest 2009;119:399–407
   PubMed Web of Science ®Google Scholar
• Heemskerk JW, Harper MT, Cosemans JM, Poole AW. Unravelling the different functions of protein kinase C isoforms in platelets. FEBS Lett 2011;585:1711–1716
   PubMed Web of Science ®Google Scholar
• Gilio K, Harper MT, Cosemans JM, Konopatskaya O, Munnix IC, Prinzen L, Leitges M, Liu Q, Molkentin JD, Heemskerk JW, et al. Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen. J Biol Chem 2010;285:23410–23419
   PubMedGoogle Scholar
• Bynagari YS, Nagy B, Jr Tuluc F, Bhavaraju K, Kim S, Vijayan KV, Kunapuli SP. Mechanism of activation and functional role of protein kinase Ceta in human platelets. J Biol Chem 2009;284:13413–13421
   Google Scholar
• Bynagari-Settipalli YS, Lakhani P, Jin J, Bhavaraju K, Rico MC, Kim S, Woulfe D, Kunapuli SP. Protein kinase C isoform epsilon negatively regulates ADP-induced calcium mobilization and thromboxane generation in platelets. Arterioscler Thromb Vasc Biol 2010;32:1211–1219
   Google Scholar
• Nagy B, Jr Bhavaraju K, Getz T, Bynagari YS, Kim S, Kunapuli SP. Impaired activation of platelets lacking protein kinase C-theta isoform. Blood 2009;113:2557–2567
   PubMed Web of Science ®Google Scholar
• Churchill EN, Qvit N, Mochly-Rosen D. Rationally designed peptide regulators of protein kinase C. Trends Endocrinol Metab 2009;20:25–33
   Google Scholar
• Kheifets V, Bright R, Inagaki K, Schechtman D, Mochly-Rosen D. Protein kinase C delta (deltaPKC)-annexin V interaction: A required step in deltaPKC translocation and function. J Biol Chem 2006;281:23218–23226
   PubMed Web of Science ®Google Scholar
• Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, Hussey AA, Evbuomwan MO, Priel DA, Kuhns DB, et al. Loss-of-function of the protein kinase C delta (PKCdelta) causes a B-cell lymphoproliferative syndrome in humans. Blood 2013;121:3117–3125
   PubMed Web of Science ®Google Scholar
• Byrne G, Freeley M, Feighery C, Whelan A, Long A. Protein kinase C delta is a substrate of tissue transglutaminase and a novel autoantigen in coeliac disease. Clin Immunol 2013;147:1–8
   Google Scholar
• Chichger H, Grinnell KL, Casserly B, Chung CS, Braza J, Lomas-Neira J, Ayala A, Rounds S, Klinger JR, Harrington EO. Genetic disruption of protein kinase Cdelta reduces endotoxin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2012;303:L880–L888
   Google Scholar
• Kilpatrick LE, Standage SW, Li H, Raj NR, Korchak HM, Wolfson MR, Deutschman CS. Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-delta (delta-PKC). J Leukoc Biol 2011;89:3–10
   PubMed Web of Science ®Google Scholar
• Morgan S, Yamanouchi D, Harberg C, Wang Q, Keller M, Si Y, Burlingham W, Seedial S, Lengfeld J, Liu B. Elevated protein kinase C-delta contributes to aneurysm pathogenesis through stimulation of apoptosis and inflammatory signaling. Arterioscler Thromb Vasc Biol 2012;32:2493–2502
   PubMedGoogle Scholar
• Getz TM, Mayanglambam A, Daniel JL, Kunapuli SP. Go6976 abrogates GPVI-mediated platelet functional responses in human platelets through inhibition of Syk. J Thromb Haemost 2011;9:608–610
   Google Scholar
• Liu Q, Chen X, Macdonnell SM, Kranias EG, Lorenz JN, Leitges M, Houser SR, Molkentin JD. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: Implications for ruboxistaurin as a novel therapeutic approach. Circ Res 2009;105:194–200
   Google Scholar